Medicare Enrolled
Dr. Kristian Delgado, M.D.
Interventional Pain Medicine Physician · Killeen, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Delgado from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delgado? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delgado
Dr. Kristian Delgado is an interventional pain medicine physician in Killeen, TX, with 18 years in practice. Based on federal Medicare data, Dr. Delgado performed 6,224 Medicare services across 2,607 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delgado received a total of $29,680 from 19 pharmaceutical and/or device companies across 1177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delgado is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 13% volume in TX$ $29,680 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,224
Medicare services
Top 13% in TX for interventional pain medicine physician
2,607
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~346 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Joint lubricant injection (TriVisc) | 1,577 | $7 | $26 |
| Office visit, established patient (30-39 min) | 1,416 | $88 | $316 |
| Dexamethasone injection (steroid) | 871 | $0 | $5 |
| Drug screening test | 408 | $60 | $350 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 287 | $195 | $497 |
| Injection, ketorolac tromethamine, per 15 mg | 138 | $0 | $3 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 124 | $71 | $226 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 94 | $70 | $439 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 94 | $242 | $617 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 89 | $39 | $213 |
| Insertion of spinal neurostimulator electrode array through skin | 78 | $230 | $5,496 |
| New patient office visit (45-59 min) | 76 | $111 | $408 |
| Office visit, established patient (20-29 min) | 73 | $66 | $223 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 67 | $45 | $413 |
| Testing for presence of drug, read by direct observation | 65 | $12 | $50 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 62 | $151 | $391 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 59 | $146 | $989 |
| Ultrasonic guidance for needle placement | 57 | $42 | $133 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 56 | $80 | $455 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 56 | $45 | $288 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 46 | $61 | $387 |
| Drug injection, under skin or into muscle | 43 | $10 | $61 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 36 | $83 | $584 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 36 | $49 | $453 |
| Insertion of spinal neurostimulator generator or receiver | 34 | $161 | $2,405 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 33 | $139 | $1,000 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 32 | $345 | $1,097 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 30 | $59 | $200 |
| Insertion of peripheral nerve neurostimulator electrode through skin | 27 | $202 | $5,234 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 26 | $38 | $261 |
| Injection of substance into lower spine canal using imaging guidance | 23 | $75 | $627 |
| Destruction of peripheral nerve or branch | 20 | $155 | $598 |
| Fluoroscopic guidance for needle placement | 19 | $20 | $271 |
| Injection of substance into middle or upper spine canal using imaging guidance | 16 | $76 | $635 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 15 | $58 | $205 |
| Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | 15 | $62 | $524 |
| Heat destruction of intraosseous basivertebral nerve in additional bone of spine in lower back | 14 | $160 | $512 |
| Fusion of spine in lower back | 12 | $1,197 | $3,789 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
55.4% medium
44.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,680
Total received (2018-2024)
Avg $4,240/year across 7 years
Top 13% in TX for interventional pain medicine physician
19
Companies
1,177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,873 (77.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,247 (17.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,560 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,846
2023$5,057
2022$7,868
2021$4,363
2020$2,484
2019$2,970
2018$1,091
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$20,432
Relievant Medsystems, Inc.
$4,622
Vertiflex, Inc.
$1,462
SPR Therapeutics, Inc
$932
Medtronic, Inc.
$544
Spinal Simplicity, LLC
$402
Nalu Medical, Inc.
$295
Vertos Medical, Inc.
$249
Curonix LLC
$194
Stimwave Technologies Incorporated
$182
BOSTON SCIENTIFIC CORPORATION
$87
PAINTEQ LLC
$63
MML US, Inc.
$49
Boston Scientific Corporation
$38
Collegium Pharmaceutical, Inc.
$35
DePuy Synthes Sales Inc.
$34
Medtronic USA, Inc.
$26
Pacira Therapeutics, Inc.
$23
PFIZER INC.
$12
Top 3 companies account for 89.3% of total payments
Associated products mentioned in payments ›
ACCURIAN · Belbuca · CHANTIX · DRG IPGs · DRG leads · ETERNA · Exclaim SCS Leads · GENERAL THERAPIES · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · Lamitrode SCS Leads · MONOVISC · NT1100 NT2000iX Simplicity · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · ORTHOVISC · Octrode SCS Leads · PAINTEQ · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · ReActiv8 · S-Series SCS Leads · SCS IPGs · SCS leads · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · SlimTip lead DRG Lead · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · VANTA ADAPTIVESTIM · XTAMPZA · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $477 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
6
Per 100K population
1.6
County median income
$66,051
Nearest hospital
ADVENTHEALTH CENTRAL TEXAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Delgado is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (low-engagement, top 13%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Delgado experienced with joint lubricant injection (trivisc)?
Based on Medicare claims data, Dr. Delgado performed 1,577 joint lubricant injection (trivisc) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delgado receive payments from pharmaceutical companies?
Yes. Dr. Delgado received a total of $29,680 from 19 companies across 1,177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delgado's costs compare to other interventional pain medicine physicians in Killeen?
Dr. Delgado's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delgado) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Killeen
Browse interventional pain medicine physicians in Killeen ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Relievant Medsystems, Inc. Payments to Doctors
See all physicians who received payments from Relievant Medsystems, Inc..
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology